Why Novavax Stock Is Sinking Again This Week

·1 min read
Why Novavax Stock Is Sinking Again This Week

Investors appear to be concerned about Pfizer's and BioNTech's head start in developing an omicron-specific vaccine.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting